Catalyst Financial Partners LLC Trims Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Catalyst Financial Partners LLC reduced its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 9.7% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 801 shares of the company’s stock after selling 86 shares during the quarter. Catalyst Financial Partners LLC’s holdings in HCA Healthcare were worth $217,000 as of its most recent filing with the SEC.

Other hedge funds have also modified their holdings of the company. Stone House Investment Management LLC acquired a new stake in HCA Healthcare during the 3rd quarter valued at approximately $25,000. Centerpoint Advisors LLC acquired a new stake in HCA Healthcare during the 4th quarter valued at approximately $27,000. Bruce G. Allen Investments LLC acquired a new stake in HCA Healthcare during the 4th quarter valued at approximately $28,000. Annis Gardner Whiting Capital Advisors LLC acquired a new stake in HCA Healthcare during the 3rd quarter valued at approximately $30,000. Finally, EdgeRock Capital LLC acquired a new stake in HCA Healthcare during the 4th quarter valued at approximately $47,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Price Performance

Shares of HCA traded up $12.48 during midday trading on Thursday, reaching $321.90. The stock had a trading volume of 1,147,815 shares, compared to its average volume of 1,096,598. HCA Healthcare, Inc. has a 52 week low of $215.96 and a 52 week high of $335.83. The company has a debt-to-equity ratio of 29.26, a current ratio of 1.16 and a quick ratio of 1.02. The firm’s 50 day moving average price is $321.17 and its 200-day moving average price is $299.35. The company has a market capitalization of $84.31 billion, a P/E ratio of 16.05, a P/E/G ratio of 1.44 and a beta of 1.66.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, April 26th. The company reported $5.36 EPS for the quarter, topping analysts’ consensus estimates of $5.01 by $0.35. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. The company had revenue of $17.34 billion for the quarter, compared to the consensus estimate of $16.81 billion. During the same quarter in the previous year, the business earned $4.93 EPS. The company’s quarterly revenue was up 11.2% compared to the same quarter last year. On average, analysts forecast that HCA Healthcare, Inc. will post 20.74 earnings per share for the current fiscal year.

HCA Healthcare declared that its Board of Directors has approved a share repurchase plan on Tuesday, January 30th that permits the company to repurchase $6.00 billion in outstanding shares. This repurchase authorization permits the company to reacquire up to 7.4% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company’s board of directors believes its stock is undervalued.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, June 28th. Investors of record on Friday, June 14th will be issued a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.82%. The ex-dividend date is Friday, June 14th. HCA Healthcare’s payout ratio is 13.16%.

Insider Buying and Selling

In other news, SVP Kathleen M. Whalen sold 4,262 shares of HCA Healthcare stock in a transaction on Friday, February 9th. The stock was sold at an average price of $306.21, for a total transaction of $1,305,067.02. Following the transaction, the senior vice president now owns 10,250 shares in the company, valued at $3,138,652.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other news, SVP Kathleen M. Whalen sold 4,262 shares of HCA Healthcare stock in a transaction on Friday, February 9th. The stock was sold at an average price of $306.21, for a total transaction of $1,305,067.02. Following the transaction, the senior vice president now owns 10,250 shares in the company, valued at $3,138,652.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Michael S. Cuffe sold 1,600 shares of HCA Healthcare stock in a transaction on Monday, May 6th. The shares were sold at an average price of $309.00, for a total value of $494,400.00. Following the transaction, the executive vice president now owns 34,124 shares in the company, valued at approximately $10,544,316. The disclosure for this sale can be found here. Insiders have sold 8,055 shares of company stock worth $2,503,100 in the last three months. 1.70% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on HCA. TD Cowen decreased their target price on HCA Healthcare from $371.00 to $360.00 and set a “buy” rating for the company in a research report on Tuesday, April 30th. Truist Financial lifted their target price on HCA Healthcare from $320.00 to $345.00 and gave the stock a “buy” rating in a research report on Wednesday, January 31st. Wells Fargo & Company lifted their target price on HCA Healthcare from $303.00 to $315.00 and gave the stock an “equal weight” rating in a research report on Thursday, March 28th. Deutsche Bank Aktiengesellschaft raised their price target on HCA Healthcare from $330.00 to $359.00 and gave the stock a “buy” rating in a report on Friday, April 12th. Finally, Raymond James raised their price target on HCA Healthcare from $300.00 to $330.00 and gave the stock an “outperform” rating in a report on Wednesday, January 31st. Four equities research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and an average target price of $316.59.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.